Ocular Therapeutix, Inc. (NASDAQ: OCUL) today announced the appointment of Michael Goldstein, M.D., M.B.A., as Chief Medical Officer. Dr. Goldstein ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE